|  | Treatments |  | |||
---|---|---|---|---|---|---|
Measurements1 | CO | FO | KO | MO | SO | TO |
Eicosanoids | Â | Â | Â | Â | Â | Â |
PGE2 metabolite (μg/d) | 2.2 ± 1.5 | 1.7 ± 1.1 | 4.6 ± 2.1 | 0.9 ± 0.04 | 1.3 ± 1.0 | 1.1 ± 0.3 |
TXB2 metabolite (μg/d) | 1474 ± 665 | 991 ± 393 | 1653 ± 447 | 807 ± 248 | 1972 ± 808 | 1359 ± 431 |
Oxidative Stability | Â | Â | Â | Â | Â | Â |
RBC TBARS (μM MDA/mL) | 9.5 ± 0.6 | 9.2 ± 0.60 | 8.5 ± 0.2 | 9.4 ± 0.5 | 10.0 ± 0.6 | 9.6 ± 0.2 |
Serum TBARS (μM MDA/mL) | 6.9 ± 0.4a | 5.9 ± 0.2ab | 6.5 ± 0.3a | 6.8 ± 0.3a | 5.1 ± 0.3b | 5.2 ± 0.2b |
Serum TAC(mM Trolox) | 1.5 ± 0.2 | 1.1 ± 0.1 | 1.3 ± 0.1 | 1.5 ± 0.2 | 1.1 ± 0.2 | 1.2 ± 0.2 |
Liver TBARS (μM MDA/g Tissue) | 220.3 ± 23.8b | 235.6 ± 21.7b | 265.1 ± 46.4b | 435.0 ± 68.8a | 198.3 ± 23.3b | 177.5 ± 14.7b |
Liver TAC (mM Trolox) | 3832 ± 421ab | 4203 ± 207ab | 3542 ± 726b | 5695 ± 727a | 2726 ± 250b | 2493 ± 195b |